A., Payne, N., Tortorelli, S., Matern, D., Rinaldo, P., Gavrilov, D., Melan, M., He, M., Steinberg, S
Clinical trials show they can reduce blood sugar, lower blood pressure and improve cardiovascular outcomes
Combination Therapies Scientists are exploring the effectiveness of GLP-1 receptor agonists when used alongside other cardiovascular medications, such as SGLT2 inhibitors, to enhance protective effects
Most GLP-1 medications require subcutaneous injection, usually in the abdomen, thigh, or upper arm
The majority of reports were submitted by consumers ( n = 6,577, 79.82%) and physicians ( n = 694, 8.42%)
In addition, in research on aging-related muscle atrophy (sarcopenia), it can promote muscle cell proliferation and differentiation, reduce muscle cell apoptosis, and enhance muscle strength and endurance by activating the SIRT1 signaling pathway